Covid-19 Impact on Global Herceptin Biosimilar Market Insights, Forecast to 2026
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Herceptin Biosimilar market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Herceptin Biosimilar industry.
Based on our recent survey, we have several different scenarios about the Herceptin Biosimilar YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Herceptin Biosimilar will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herceptin Biosimilar market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herceptin Biosimilar market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Herceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Herceptin Biosimilar market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Herceptin Biosimilar market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Herceptin Biosimilar market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herceptin Biosimilar market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herceptin Biosimilar market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Herceptin Biosimilar market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Herceptin Biosimilar industry.
Based on our recent survey, we have several different scenarios about the Herceptin Biosimilar YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Herceptin Biosimilar will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Herceptin Biosimilar market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Herceptin Biosimilar market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Herceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Herceptin Biosimilar market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Herceptin Biosimilar market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Herceptin Biosimilar market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Herceptin Biosimilar market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Herceptin Biosimilar market.
The following manufacturers are covered in this report:
- Amgen
- AryoGen Biopharma
- Biocon
- Celltrion
- Gedeon Richter
- Genor Biopharma
- Mabion
- Mylan
- Roche
- The Instituto Vital Brazil
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Lymphoma
- Other
- Hospital & Clinics
- Oncology Centers
- Other
1 STUDY COVERAGE
1.1 Herceptin Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Herceptin Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herceptin Biosimilar Market Size Growth Rate by Type
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Leukemia
1.4.5 Lymphoma
1.4.6 Other
1.5 Market by Application
1.5.1 Global Herceptin Biosimilar Market Size Growth Rate by Application
1.5.2 Hospital & Clinics
1.5.3 Oncology Centers
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Herceptin Biosimilar Industry Impact
1.6.1 How the Covid-19 is Affecting the Herceptin Biosimilar Industry
1.6.1.1 Herceptin Biosimilar Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Herceptin Biosimilar Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Herceptin Biosimilar Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Herceptin Biosimilar Market Size Estimates and Forecasts
2.1.1 Global Herceptin Biosimilar Revenue 2015-2026
2.1.2 Global Herceptin Biosimilar Sales 2015-2026
2.2 Herceptin Biosimilar Market Size by Region: 2020 Versus 2026
2.2.1 Global Herceptin Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Herceptin Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HERCEPTIN BIOSIMILAR COMPETITOR LANDSCAPE BY PLAYERS
3.1 Herceptin Biosimilar Sales by Manufacturers
3.1.1 Herceptin Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Herceptin Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Herceptin Biosimilar Revenue by Manufacturers
3.2.1 Herceptin Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Herceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herceptin Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herceptin Biosimilar Revenue in 2019
3.2.5 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Herceptin Biosimilar Price by Manufacturers
3.4 Herceptin Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Herceptin Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herceptin Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Herceptin Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Herceptin Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Herceptin Biosimilar Sales by Type (2015-2020)
4.1.2 Global Herceptin Biosimilar Revenue by Type (2015-2020)
4.1.3 Herceptin Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herceptin Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Herceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Herceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Herceptin Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herceptin Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Herceptin Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Herceptin Biosimilar Sales by Application (2015-2020)
5.1.2 Global Herceptin Biosimilar Revenue by Application (2015-2020)
5.1.3 Herceptin Biosimilar Price by Application (2015-2020)
5.2 Herceptin Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Herceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Herceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Herceptin Biosimilar Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Herceptin Biosimilar by Country
6.1.1 North America Herceptin Biosimilar Sales by Country
6.1.2 North America Herceptin Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Herceptin Biosimilar Market Facts & Figures by Type
6.3 North America Herceptin Biosimilar Market Facts & Figures by Application
7 EUROPE
7.1 Europe Herceptin Biosimilar by Country
7.1.1 Europe Herceptin Biosimilar Sales by Country
7.1.2 Europe Herceptin Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herceptin Biosimilar Market Facts & Figures by Type
7.3 Europe Herceptin Biosimilar Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Herceptin Biosimilar by Region
8.1.1 Asia Pacific Herceptin Biosimilar Sales by Region
8.1.2 Asia Pacific Herceptin Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Herceptin Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Herceptin Biosimilar Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Herceptin Biosimilar by Country
9.1.1 Latin America Herceptin Biosimilar Sales by Country
9.1.2 Latin America Herceptin Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Herceptin Biosimilar Market Facts & Figures by Type
9.3 Central & South America Herceptin Biosimilar Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Herceptin Biosimilar by Country
10.1.1 Middle East and Africa Herceptin Biosimilar Sales by Country
10.1.2 Middle East and Africa Herceptin Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Herceptin Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Herceptin Biosimilar Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Herceptin Biosimilar Products Offered
11.1.5 Amgen Recent Development
11.2 AryoGen Biopharma
11.2.1 AryoGen Biopharma Corporation Information
11.2.2 AryoGen Biopharma Description, Business Overview and Total Revenue
11.2.3 AryoGen Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AryoGen Biopharma Herceptin Biosimilar Products Offered
11.2.5 AryoGen Biopharma Recent Development
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description, Business Overview and Total Revenue
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Herceptin Biosimilar Products Offered
11.3.5 Biocon Recent Development
11.4 Celltrion
11.4.1 Celltrion Corporation Information
11.4.2 Celltrion Description, Business Overview and Total Revenue
11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Herceptin Biosimilar Products Offered
11.4.5 Celltrion Recent Development
11.5 Gedeon Richter
11.5.1 Gedeon Richter Corporation Information
11.5.2 Gedeon Richter Description, Business Overview and Total Revenue
11.5.3 Gedeon Richter Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
11.5.5 Gedeon Richter Recent Development
11.6 Genor Biopharma
11.6.1 Genor Biopharma Corporation Information
11.6.2 Genor Biopharma Description, Business Overview and Total Revenue
11.6.3 Genor Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
11.6.5 Genor Biopharma Recent Development
11.7 Mabion
11.7.1 Mabion Corporation Information
11.7.2 Mabion Description, Business Overview and Total Revenue
11.7.3 Mabion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mabion Herceptin Biosimilar Products Offered
11.7.5 Mabion Recent Development
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description, Business Overview and Total Revenue
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan Herceptin Biosimilar Products Offered
11.8.5 Mylan Recent Development
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Description, Business Overview and Total Revenue
11.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Roche Herceptin Biosimilar Products Offered
11.9.5 Roche Recent Development
11.10 The Instituto Vital Brazil
11.10.1 The Instituto Vital Brazil Corporation Information
11.10.2 The Instituto Vital Brazil Description, Business Overview and Total Revenue
11.10.3 The Instituto Vital Brazil Sales, Revenue and Gross Margin (2015-2020)
11.10.4 The Instituto Vital Brazil Herceptin Biosimilar Products Offered
11.10.5 The Instituto Vital Brazil Recent Development
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Herceptin Biosimilar Products Offered
11.1.5 Amgen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Herceptin Biosimilar Market Estimates and Projections by Region
12.1.1 Global Herceptin Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Herceptin Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Herceptin Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Herceptin Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Herceptin Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Herceptin Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Herceptin Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Herceptin Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Herceptin Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Herceptin Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Herceptin Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Herceptin Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Herceptin Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Herceptin Biosimilar Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Herceptin Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Herceptin Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Herceptin Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herceptin Biosimilar Market Size Growth Rate by Type
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Leukemia
1.4.5 Lymphoma
1.4.6 Other
1.5 Market by Application
1.5.1 Global Herceptin Biosimilar Market Size Growth Rate by Application
1.5.2 Hospital & Clinics
1.5.3 Oncology Centers
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Herceptin Biosimilar Industry Impact
1.6.1 How the Covid-19 is Affecting the Herceptin Biosimilar Industry
1.6.1.1 Herceptin Biosimilar Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Herceptin Biosimilar Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Herceptin Biosimilar Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Herceptin Biosimilar Market Size Estimates and Forecasts
2.1.1 Global Herceptin Biosimilar Revenue 2015-2026
2.1.2 Global Herceptin Biosimilar Sales 2015-2026
2.2 Herceptin Biosimilar Market Size by Region: 2020 Versus 2026
2.2.1 Global Herceptin Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Herceptin Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HERCEPTIN BIOSIMILAR COMPETITOR LANDSCAPE BY PLAYERS
3.1 Herceptin Biosimilar Sales by Manufacturers
3.1.1 Herceptin Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Herceptin Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Herceptin Biosimilar Revenue by Manufacturers
3.2.1 Herceptin Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Herceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herceptin Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herceptin Biosimilar Revenue in 2019
3.2.5 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Herceptin Biosimilar Price by Manufacturers
3.4 Herceptin Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Herceptin Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herceptin Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Herceptin Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Herceptin Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Herceptin Biosimilar Sales by Type (2015-2020)
4.1.2 Global Herceptin Biosimilar Revenue by Type (2015-2020)
4.1.3 Herceptin Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herceptin Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Herceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Herceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Herceptin Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herceptin Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Herceptin Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Herceptin Biosimilar Sales by Application (2015-2020)
5.1.2 Global Herceptin Biosimilar Revenue by Application (2015-2020)
5.1.3 Herceptin Biosimilar Price by Application (2015-2020)
5.2 Herceptin Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Herceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Herceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Herceptin Biosimilar Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Herceptin Biosimilar by Country
6.1.1 North America Herceptin Biosimilar Sales by Country
6.1.2 North America Herceptin Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Herceptin Biosimilar Market Facts & Figures by Type
6.3 North America Herceptin Biosimilar Market Facts & Figures by Application
7 EUROPE
7.1 Europe Herceptin Biosimilar by Country
7.1.1 Europe Herceptin Biosimilar Sales by Country
7.1.2 Europe Herceptin Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herceptin Biosimilar Market Facts & Figures by Type
7.3 Europe Herceptin Biosimilar Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Herceptin Biosimilar by Region
8.1.1 Asia Pacific Herceptin Biosimilar Sales by Region
8.1.2 Asia Pacific Herceptin Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Herceptin Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Herceptin Biosimilar Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Herceptin Biosimilar by Country
9.1.1 Latin America Herceptin Biosimilar Sales by Country
9.1.2 Latin America Herceptin Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Herceptin Biosimilar Market Facts & Figures by Type
9.3 Central & South America Herceptin Biosimilar Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Herceptin Biosimilar by Country
10.1.1 Middle East and Africa Herceptin Biosimilar Sales by Country
10.1.2 Middle East and Africa Herceptin Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Herceptin Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Herceptin Biosimilar Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Herceptin Biosimilar Products Offered
11.1.5 Amgen Recent Development
11.2 AryoGen Biopharma
11.2.1 AryoGen Biopharma Corporation Information
11.2.2 AryoGen Biopharma Description, Business Overview and Total Revenue
11.2.3 AryoGen Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AryoGen Biopharma Herceptin Biosimilar Products Offered
11.2.5 AryoGen Biopharma Recent Development
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description, Business Overview and Total Revenue
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Herceptin Biosimilar Products Offered
11.3.5 Biocon Recent Development
11.4 Celltrion
11.4.1 Celltrion Corporation Information
11.4.2 Celltrion Description, Business Overview and Total Revenue
11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Herceptin Biosimilar Products Offered
11.4.5 Celltrion Recent Development
11.5 Gedeon Richter
11.5.1 Gedeon Richter Corporation Information
11.5.2 Gedeon Richter Description, Business Overview and Total Revenue
11.5.3 Gedeon Richter Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
11.5.5 Gedeon Richter Recent Development
11.6 Genor Biopharma
11.6.1 Genor Biopharma Corporation Information
11.6.2 Genor Biopharma Description, Business Overview and Total Revenue
11.6.3 Genor Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
11.6.5 Genor Biopharma Recent Development
11.7 Mabion
11.7.1 Mabion Corporation Information
11.7.2 Mabion Description, Business Overview and Total Revenue
11.7.3 Mabion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mabion Herceptin Biosimilar Products Offered
11.7.5 Mabion Recent Development
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description, Business Overview and Total Revenue
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan Herceptin Biosimilar Products Offered
11.8.5 Mylan Recent Development
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Description, Business Overview and Total Revenue
11.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Roche Herceptin Biosimilar Products Offered
11.9.5 Roche Recent Development
11.10 The Instituto Vital Brazil
11.10.1 The Instituto Vital Brazil Corporation Information
11.10.2 The Instituto Vital Brazil Description, Business Overview and Total Revenue
11.10.3 The Instituto Vital Brazil Sales, Revenue and Gross Margin (2015-2020)
11.10.4 The Instituto Vital Brazil Herceptin Biosimilar Products Offered
11.10.5 The Instituto Vital Brazil Recent Development
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description, Business Overview and Total Revenue
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Herceptin Biosimilar Products Offered
11.1.5 Amgen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Herceptin Biosimilar Market Estimates and Projections by Region
12.1.1 Global Herceptin Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Herceptin Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Herceptin Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Herceptin Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Herceptin Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Herceptin Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Herceptin Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Herceptin Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Herceptin Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Herceptin Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Herceptin Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Herceptin Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Herceptin Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Herceptin Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Herceptin Biosimilar Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Herceptin Biosimilar Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Herceptin Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Herceptin Biosimilar Market Segments
Table 2. Ranking of Global Top Herceptin Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herceptin Biosimilar Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Breast Cancer
Table 5. Major Manufacturers of Colorectal Cancer
Table 6. Major Manufacturers of Leukemia
Table 7. Major Manufacturers of Lymphoma
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Herceptin Biosimilar Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Herceptin Biosimilar Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Herceptin Biosimilar Players to Combat Covid-19 Impact
Table 14. Global Herceptin Biosimilar Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Herceptin Biosimilar Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 16. Global Herceptin Biosimilar Sales by Regions 2015-2020 (K Units)
Table 17. Global Herceptin Biosimilar Sales Market Share by Regions (2015-2020)
Table 18. Global Herceptin Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Herceptin Biosimilar Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Herceptin Biosimilar Sales Share by Manufacturers (2015-2020)
Table 21. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Herceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019)
Table 23. Herceptin Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Herceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Herceptin Biosimilar Price (2015-2020) (USD/Unit)
Table 26. Herceptin Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Herceptin Biosimilar Product Type
Table 28. Date of International Manufacturers Enter into Herceptin Biosimilar Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 31. Global Herceptin Biosimilar Sales Share by Type (2015-2020)
Table 32. Global Herceptin Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Herceptin Biosimilar Revenue Share by Type (2015-2020)
Table 34. Herceptin Biosimilar Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 35. Global Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 36. Global Herceptin Biosimilar Sales Share by Application (2015-2020)
Table 37. North America Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 38. North America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 39. North America Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 41. North America Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 42. North America Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 43. North America Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 44. North America Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Europe Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 46. Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 47. Europe Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 49. Europe Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 50. Europe Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 51. Europe Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 52. Europe Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Herceptin Biosimilar Sales by Region (2015-2020) (K Units)
Table 54. Asia Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Herceptin Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 58. Asia Pacific Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 60. Asia Pacific Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 61. Latin America Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 62. Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 65. Latin America Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 66. Latin America Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Latin America Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 68. Latin America Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 70. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 74. Middle East and Africa Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 76. Middle East and Africa Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 77. Amgen Corporation Information
Table 78. Amgen Description and Major Businesses
Table 79. Amgen Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Amgen Product
Table 81. Amgen Recent Development
Table 82. AryoGen Biopharma Corporation Information
Table 83. AryoGen Biopharma Description and Major Businesses
Table 84. AryoGen Biopharma Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. AryoGen Biopharma Product
Table 86. AryoGen Biopharma Recent Development
Table 87. Biocon Corporation Information
Table 88. Biocon Description and Major Businesses
Table 89. Biocon Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Biocon Product
Table 91. Biocon Recent Development
Table 92. Celltrion Corporation Information
Table 93. Celltrion Description and Major Businesses
Table 94. Celltrion Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Celltrion Product
Table 96. Celltrion Recent Development
Table 97. Gedeon Richter Corporation Information
Table 98. Gedeon Richter Description and Major Businesses
Table 99. Gedeon Richter Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Gedeon Richter Product
Table 101. Gedeon Richter Recent Development
Table 102. Genor Biopharma Corporation Information
Table 103. Genor Biopharma Description and Major Businesses
Table 104. Genor Biopharma Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Genor Biopharma Product
Table 106. Genor Biopharma Recent Development
Table 107. Mabion Corporation Information
Table 108. Mabion Description and Major Businesses
Table 109. Mabion Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Mabion Product
Table 111. Mabion Recent Development
Table 112. Mylan Corporation Information
Table 113. Mylan Description and Major Businesses
Table 114. Mylan Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Mylan Product
Table 116. Mylan Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Major Businesses
Table 119. Roche Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Roche Product
Table 121. Roche Recent Development
Table 122. The Instituto Vital Brazil Corporation Information
Table 123. The Instituto Vital Brazil Description and Major Businesses
Table 124. The Instituto Vital Brazil Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. The Instituto Vital Brazil Product
Table 126. The Instituto Vital Brazil Recent Development
Table 127. Global Herceptin Biosimilar Sales Forecast by Regions (2021-2026) (K Units)
Table 128. Global Herceptin Biosimilar Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Herceptin Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Herceptin Biosimilar Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 132. North America: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 134. Europe: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Herceptin Biosimilar Sales Forecast by Region (2021-2026) (K Units)
Table 136. Asia Pacific: Herceptin Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 138. Latin America: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 140. Middle East and Africa: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Herceptin Biosimilar Players
Table 145. Herceptin Biosimilar Customers List
Table 146. Herceptin Biosimilar Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Herceptin Biosimilar Market Segments
Table 2. Ranking of Global Top Herceptin Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herceptin Biosimilar Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Breast Cancer
Table 5. Major Manufacturers of Colorectal Cancer
Table 6. Major Manufacturers of Leukemia
Table 7. Major Manufacturers of Lymphoma
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Herceptin Biosimilar Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Herceptin Biosimilar Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Herceptin Biosimilar Players to Combat Covid-19 Impact
Table 14. Global Herceptin Biosimilar Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Herceptin Biosimilar Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 16. Global Herceptin Biosimilar Sales by Regions 2015-2020 (K Units)
Table 17. Global Herceptin Biosimilar Sales Market Share by Regions (2015-2020)
Table 18. Global Herceptin Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Herceptin Biosimilar Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Herceptin Biosimilar Sales Share by Manufacturers (2015-2020)
Table 21. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Herceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019)
Table 23. Herceptin Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Herceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Herceptin Biosimilar Price (2015-2020) (USD/Unit)
Table 26. Herceptin Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Herceptin Biosimilar Product Type
Table 28. Date of International Manufacturers Enter into Herceptin Biosimilar Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 31. Global Herceptin Biosimilar Sales Share by Type (2015-2020)
Table 32. Global Herceptin Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Herceptin Biosimilar Revenue Share by Type (2015-2020)
Table 34. Herceptin Biosimilar Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 35. Global Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 36. Global Herceptin Biosimilar Sales Share by Application (2015-2020)
Table 37. North America Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 38. North America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 39. North America Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 41. North America Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 42. North America Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 43. North America Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 44. North America Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Europe Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 46. Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 47. Europe Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 49. Europe Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 50. Europe Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 51. Europe Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 52. Europe Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Herceptin Biosimilar Sales by Region (2015-2020) (K Units)
Table 54. Asia Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Herceptin Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 58. Asia Pacific Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 60. Asia Pacific Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 61. Latin America Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 62. Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 65. Latin America Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 66. Latin America Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Latin America Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 68. Latin America Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Herceptin Biosimilar Sales by Country (2015-2020) (K Units)
Table 70. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Herceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 74. Middle East and Africa Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 76. Middle East and Africa Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 77. Amgen Corporation Information
Table 78. Amgen Description and Major Businesses
Table 79. Amgen Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Amgen Product
Table 81. Amgen Recent Development
Table 82. AryoGen Biopharma Corporation Information
Table 83. AryoGen Biopharma Description and Major Businesses
Table 84. AryoGen Biopharma Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. AryoGen Biopharma Product
Table 86. AryoGen Biopharma Recent Development
Table 87. Biocon Corporation Information
Table 88. Biocon Description and Major Businesses
Table 89. Biocon Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Biocon Product
Table 91. Biocon Recent Development
Table 92. Celltrion Corporation Information
Table 93. Celltrion Description and Major Businesses
Table 94. Celltrion Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Celltrion Product
Table 96. Celltrion Recent Development
Table 97. Gedeon Richter Corporation Information
Table 98. Gedeon Richter Description and Major Businesses
Table 99. Gedeon Richter Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Gedeon Richter Product
Table 101. Gedeon Richter Recent Development
Table 102. Genor Biopharma Corporation Information
Table 103. Genor Biopharma Description and Major Businesses
Table 104. Genor Biopharma Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Genor Biopharma Product
Table 106. Genor Biopharma Recent Development
Table 107. Mabion Corporation Information
Table 108. Mabion Description and Major Businesses
Table 109. Mabion Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Mabion Product
Table 111. Mabion Recent Development
Table 112. Mylan Corporation Information
Table 113. Mylan Description and Major Businesses
Table 114. Mylan Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Mylan Product
Table 116. Mylan Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Major Businesses
Table 119. Roche Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Roche Product
Table 121. Roche Recent Development
Table 122. The Instituto Vital Brazil Corporation Information
Table 123. The Instituto Vital Brazil Description and Major Businesses
Table 124. The Instituto Vital Brazil Herceptin Biosimilar Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. The Instituto Vital Brazil Product
Table 126. The Instituto Vital Brazil Recent Development
Table 127. Global Herceptin Biosimilar Sales Forecast by Regions (2021-2026) (K Units)
Table 128. Global Herceptin Biosimilar Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Herceptin Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Herceptin Biosimilar Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 132. North America: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 134. Europe: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Herceptin Biosimilar Sales Forecast by Region (2021-2026) (K Units)
Table 136. Asia Pacific: Herceptin Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 138. Latin America: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Herceptin Biosimilar Sales Forecast by Country (2021-2026) (K Units)
Table 140. Middle East and Africa: Herceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Herceptin Biosimilar Players
Table 145. Herceptin Biosimilar Customers List
Table 146. Herceptin Biosimilar Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Herceptin Biosimilar Product Picture
Figure 2. Global Herceptin Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Breast Cancer Product Picture
Figure 4. Colorectal Cancer Product Picture
Figure 5. Leukemia Product Picture
Figure 6. Lymphoma Product Picture
Figure 7. Other Product Picture
Figure 8. Global Herceptin Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital & Clinics
Figure 10. Oncology Centers
Figure 11. Other
Figure 12. Herceptin Biosimilar Report Years Considered
Figure 13. Global Herceptin Biosimilar Market Size 2015-2026 (US$ Million)
Figure 14. Global Herceptin Biosimilar Sales 2015-2026 (K Units)
Figure 15. Global Herceptin Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Figure 17. Global Herceptin Biosimilar Sales Market Share by Region in 2019
Figure 18. Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Figure 19. Global Herceptin Biosimilar Revenue Market Share by Region in 2019
Figure 20. Global Herceptin Biosimilar Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Herceptin Biosimilar Revenue in 2019
Figure 22. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Figure 24. Global Herceptin Biosimilar Sales Market Share by Type in 2019
Figure 25. Global Herceptin Biosimilar Revenue Market Share by Type (2015-2020)
Figure 26. Global Herceptin Biosimilar Revenue Market Share by Type in 2019
Figure 27. Global Herceptin Biosimilar Market Share by Price Range (2015-2020)
Figure 28. Global Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Figure 29. Global Herceptin Biosimilar Sales Market Share by Application in 2019
Figure 30. Global Herceptin Biosimilar Revenue Market Share by Application (2015-2020)
Figure 31. Global Herceptin Biosimilar Revenue Market Share by Application in 2019
Figure 32. North America Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 35. North America Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 36. U.S. Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Herceptin Biosimilar Market Share by Type in 2019
Figure 41. North America Herceptin Biosimilar Market Share by Application in 2019
Figure 42. Europe Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 45. Europe Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 46. Germany Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Herceptin Biosimilar Market Share by Type in 2019
Figure 57. Europe Herceptin Biosimilar Market Share by Application in 2019
Figure 58. Asia Pacific Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Herceptin Biosimilar Sales Market Share by Region in 2019
Figure 61. Asia Pacific Herceptin Biosimilar Revenue Market Share by Region in 2019
Figure 62. China Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Herceptin Biosimilar Market Share by Type in 2019
Figure 85. Asia Pacific Herceptin Biosimilar Market Share by Application in 2019
Figure 86. Latin America Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 89. Latin America Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 90. Mexico Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Herceptin Biosimilar Market Share by Type in 2019
Figure 97. Latin America Herceptin Biosimilar Market Share by Application in 2019
Figure 98. Middle East and Africa Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 102. Turkey Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Herceptin Biosimilar Market Share by Type in 2019
Figure 109. Middle East and Africa Herceptin Biosimilar Market Share by Application in 2019
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. AryoGen Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Genor Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Mabion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. The Instituto Vital Brazil Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. North America Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Europe Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Asia Pacific Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Latin America Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Middle East and Africa Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
Figure 1. Herceptin Biosimilar Product Picture
Figure 2. Global Herceptin Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Breast Cancer Product Picture
Figure 4. Colorectal Cancer Product Picture
Figure 5. Leukemia Product Picture
Figure 6. Lymphoma Product Picture
Figure 7. Other Product Picture
Figure 8. Global Herceptin Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital & Clinics
Figure 10. Oncology Centers
Figure 11. Other
Figure 12. Herceptin Biosimilar Report Years Considered
Figure 13. Global Herceptin Biosimilar Market Size 2015-2026 (US$ Million)
Figure 14. Global Herceptin Biosimilar Sales 2015-2026 (K Units)
Figure 15. Global Herceptin Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Figure 17. Global Herceptin Biosimilar Sales Market Share by Region in 2019
Figure 18. Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Figure 19. Global Herceptin Biosimilar Revenue Market Share by Region in 2019
Figure 20. Global Herceptin Biosimilar Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Herceptin Biosimilar Revenue in 2019
Figure 22. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Herceptin Biosimilar Sales Market Share by Type (2015-2020)
Figure 24. Global Herceptin Biosimilar Sales Market Share by Type in 2019
Figure 25. Global Herceptin Biosimilar Revenue Market Share by Type (2015-2020)
Figure 26. Global Herceptin Biosimilar Revenue Market Share by Type in 2019
Figure 27. Global Herceptin Biosimilar Market Share by Price Range (2015-2020)
Figure 28. Global Herceptin Biosimilar Sales Market Share by Application (2015-2020)
Figure 29. Global Herceptin Biosimilar Sales Market Share by Application in 2019
Figure 30. Global Herceptin Biosimilar Revenue Market Share by Application (2015-2020)
Figure 31. Global Herceptin Biosimilar Revenue Market Share by Application in 2019
Figure 32. North America Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 35. North America Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 36. U.S. Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Herceptin Biosimilar Market Share by Type in 2019
Figure 41. North America Herceptin Biosimilar Market Share by Application in 2019
Figure 42. Europe Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 45. Europe Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 46. Germany Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Herceptin Biosimilar Market Share by Type in 2019
Figure 57. Europe Herceptin Biosimilar Market Share by Application in 2019
Figure 58. Asia Pacific Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Herceptin Biosimilar Sales Market Share by Region in 2019
Figure 61. Asia Pacific Herceptin Biosimilar Revenue Market Share by Region in 2019
Figure 62. China Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Herceptin Biosimilar Market Share by Type in 2019
Figure 85. Asia Pacific Herceptin Biosimilar Market Share by Application in 2019
Figure 86. Latin America Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 89. Latin America Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 90. Mexico Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Herceptin Biosimilar Market Share by Type in 2019
Figure 97. Latin America Herceptin Biosimilar Market Share by Application in 2019
Figure 98. Middle East and Africa Herceptin Biosimilar Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Herceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country in 2019
Figure 102. Turkey Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Herceptin Biosimilar Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Herceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Herceptin Biosimilar Market Share by Type in 2019
Figure 109. Middle East and Africa Herceptin Biosimilar Market Share by Application in 2019
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. AryoGen Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Genor Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Mabion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. The Instituto Vital Brazil Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. North America Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Europe Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Asia Pacific Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Latin America Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Herceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Middle East and Africa Herceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
